What Researchers Did
Researchers retrospectively evaluated the effectiveness of intratympanic steroid injections versus hyperbaric oxygen therapy as salvage treatments for patients with refractory sudden sensorineural hearing loss.
What They Found
The study found that both intratympanic steroid injections and hyperbaric oxygen therapy yielded similar results for improving hearing in patients with refractory sudden sensorineural hearing loss.
Changes in pure tone averages (p=0.364) and speech discrimination scores (p=0.113) were not significantly different between the two salvage therapies.
What This Means for Canadian Patients
For Canadian patients experiencing refractory sudden sensorineural hearing loss, this study suggests that both intratympanic steroid injections and hyperbaric oxygen therapy could be considered equally effective salvage treatment options.
Patients and their clinicians may choose between these therapies based on accessibility, cost, and individual patient factors.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Brazil.
Study Limitations
A key limitation of this study is its retrospective design, which may introduce selection bias and limit the generalizability of the findings.